Adherence to antiretroviral therapy (ART) is essential to its effectiveness and avoidance of the development of drug-resistant HIV strains. Many studies have been undertaken on factors affecting adherence to ART; however, there is little information about Laos. Hence, this qualitative study examines barriers to and facilitators of adherence specific to this context. In-depth interviews and focus group discussions were undertaken with 43 people living with HIV (PLHIV) currently on ART across 2 hospitals in Laos: Setthathirath hospital in the capital Vientiane and Savannakhet Province hospital. Interviews were based on semistructured question guides and were undertaken in Lao, translated into English and audio-recorded for later analysis. Major barriers to adherence reported by participants included transport costs, distance to the hospital, and stigma and discrimination. Key facilitators discussed were the perceived benefits of medication, social support, and the acceptance of HIV status
BruntonLLLazoJSParkerKL. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. Chapter 50: Antiretroviral Agents and Treatment of HIV Infection. 11th ed.The McGraw-Hill; 2006.
OsterbergLBlaschkeT. Adherence to medication. N Engl J Med. 2005;353:487-497.
5.
RaffaJDTossonianHKGrebelyJPetkauAJDeVlamingSConwayB. Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations. J Acquir Immune Defic Syndr. 2008;47:397-399.
6.
MaggioloFAiroldiMKleinloogHD. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI or PI treated patients. HIV Clin Trials. 2007;8:282-292.
7.
BeyeneKAGedifTGebre-MariamTEngidaworkE. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia. Pharmacoepidemiol Drug Saf. 2009;18:1007-1015.
8.
BoyerSMarcellingFOngolo-ZogoP. Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ. 2009;87:279-287.
9.
HardonAPAkurutDComoroC. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658-665.
10.
PosseMMeheusFAstenHvVen Avd BaltussenR. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health. 2008;13:904-913.
11.
CuriosoWHKepkaDCabelloRSeguraPKurthAE. Understanding the facilitators and barriers of antiretroviral adherence in Peru: a qualitative study. BMC Public Health. 2010;10:13.
12.
MelchiorRNemesMIBAlencarTMDBuchallaCM. Challenges of treatment adherence by people living with HIV/AIDS in Brazil. Rev Saude Publica. 2007;41(suppl 2):87-93.
13.
NamSLFieldingKAvalosADickinsonDGaolatheTGeisslerPW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 2008;67:301-310.
14.
SabinLLDesilvaMBHamerDH. Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study. AIDS Care. 2008;20:1242-1250.
15.
TalamNCGatongiPRotichJKimaiyoS. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi teaching and referral hospital, Eldoret, Kenya. East Afr J Public Health. 2008;5:74-78.
16.
DahabMCharalambousSHamiltonR. “That is why I stopped the ART”: patients’ and providers’ perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:1471-2458.
17.
GrantELogieDMasuraMGormanDMurraySA. Factors facilitating and challenging access and adherence to antiretroviral therapy in a town in the Zambian Copperbelt: a qualitative study. AIDS Care. 2008;20:1155-1160.
18.
WattMHMamanSEarpJA. “It’s all the time in my mind”: Facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med. 2009;68:1793-1800.
19.
KnodelJKespichayawattanaJSaengtienchaiCWiwatwanichS. The role of parent and family members in ART treatment adherence: evidence from Thailand. Res Aging. 2010;32:19-39.
20.
MurrayLKSemrauKMcCurleyE. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21:78-86.
21.
HossainMBKippaxS. Stigmatized attitudes toward people living with HIV in Bangladesh: health care workers’ perspectives. Asia Pac J Public Health. 2011;23:171-182.
22.
PhrasisombathKThomsenSHagbergJSychareumVFaxelidE. Knowledge about sexually transmitted infections (STIs) and attitudes toward female sex workers with STI symptoms among health care providers in Laos. Asia Pac J Public Health. 2012;24(6):940-952.
23.
KumarasamyNSafrenSARaminaniSR. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDS. 2005;19:526-537.
